real estate news
Aurobindo Pharma Promoters Secure Rs 2,000 Crore for Real Estate Ventures
Aurobindo Pharma's promoter group has raised Rs 2,000 crore through a structured financing deal for their real estate arm, Auro Realty. This strategic move aims to fund platform acquisitions and secure assets like the Taj Banjara in Hyderabad.
Real Estate
Top 5 Stocks with Recent Promoter Buying: A Show of Faith in Company Growth
In the last week, several promoters and insiders have shown confidence in their companies by acquiring additional stakes. Here are the top 5 stocks that saw promoter buying, signaling a bullish outlook.
Real Estate
Stocks to Watch: KFin Technologies, Brigade Enterprises, RVNL, and More
Key stocks to watch include KFin Technologies, Brigade Enterprises, and KEC International, among others, as they make significant moves in their respective sectors. IT stocks are also expected to be in focus following recent H-1B visa rule changes.
real estate news
Aurobindo Pharma Poised for Strong Rally Post-Consolidation: Religare Broking
Religare Broking's Ajit Mishra suggests that Aurobindo Pharma is set for a significant rally after a period of consolidation. Traders are advised to buy the stock with a target of Rs 1,300 over the next 1-2 months.
real estate news
Two Stocks to Buy Now for a Potential Upside of 40%; Recommendations by Trade Brains Portal
Discover two promising stocks from the real estate and pharmaceutical sectors, recommended by Trade Brains Portal, with the potential for significant gains.
Real Estate
Top 7 Richest People in Telangana and Their Net Worth in 2025
From pharmaceuticals to infrastructure, real estate to renewable energy, Telangana's billionaires are shaping industries, creating jobs, and influencing global markets.
real estate news
SMC Global’s Shitij Gandhi: Buy Dr. Reddy’s for Rs 1,360 Target
SMC Global’s Senior Technical Analyst, Shitij Gandhi, advises traders to accumulate Dr. Reddy’s Laboratories stock for a target of Rs 1,360 in the next 5-7 weeks, following a strong technical breakout.
Real Estate Mumbai
8 High-Potential Stocks to Buy Now for an Upside of up to 80%
Discover 8 promising stocks with potential upsides ranging from 38.6% to 78.4%, including real estate, IT, and retail sectors. Do you own any of these gems?
real estate news
Mumbai's Elite: The 10 Richest Billionaires of 2025
Mumbai, the financial capital of India, is home to some of the wealthiest individuals in the country. From business tycoons to pharma giants, here’s a look at the top 10 richest people in Mumbai in 2025.
real estate news
KTR Criticizes Congress's 'Future City' Project in Telangana
KT Rama Rao, BRS Working President, strongly condemns the Congress government's 'Future City' project, accusing Chief Minister A Revanth Reddy of misusing Pharma City lands for real estate benefits.
real estate news
BRS President KTR Accuses CM Revanth Reddy of Misusing Pharma City Land for Real Estate
KT Rama Rao, the BRS working president, has accused Chief Minister Revanth Reddy of turning the scrapped Hyderabad Pharma City project into a real estate venture, misusing farmers’ lands and public money.
Real Estate
Healthcare Highlights: Real Estate Deals and AI Advancements
Explore the latest in healthcare, from major real estate transactions to groundbreaking AI investments, and the ongoing legal battles shaping the industry.
Real Estate Mumbai
Pharmaceutical Magnates Invest Heavily in Mumbai's Luxury Real Estate
The promoter family of Blue Jet Healthcare has made substantial investments in Mumbai’s luxury real estate market, acquiring three high-end apartments in Worli for a combined value of ₹202 crore, highlighting the growing influence of pharmaceutical wealth in premium residential properties.
Real Estate
Pharmaceutical Wealth Drives Luxury Real Estate in Mumbai: Blue Jet Healthcare’s Major Acquisition
Mumbai's luxury real estate market continues to thrive, with Blue Jet Healthcare's promoter family making a significant investment by acquiring three premium apartments in Worli for ₹202 crore. This trend highlights the growing influence of pharmaceutical sector wealth in the city's premium property segment.
real estate news
Pharma Wealth Drives Luxury Real Estate Market: Blue Jet Healthcare Acquires ₹202 Crore Properties in Worli
Blue Jet Healthcare promoters have made significant investments in Mumbai’s luxury real estate market by acquiring three high-end apartments in Worli for a combined value of ₹202 crore. This reflects the growing influence of pharmaceutical sector wealth in Mumbai’s premium residential property segment.
real estate news
Pharma Wealth Boosts Mumbai Real Estate: Blue Jet Healthcare Promoter Buys Luxurious Worli Apartments
The promoter of Blue Jet Healthcare and his family have acquired three high-end apartments in Worli, Mumbai, for over ₹202 crore, reflecting the growing investment in luxury real estate by pharmaceutical tycoons.
Real Estate Mumbai
Pharma Wealth Booms: Blue Jet Healthcare Promoter Family Buys Luxury Worli Apartments for Over ₹202 Crore
In a significant move, the promoter of Blue Jet Healthcare and his family have acquired three luxury apartments in Worli, Mumbai, for more than ₹202 crore, highlighting the growing trend of pharma wealth in the city's high-end real estate market.
Real Estate
Pharma Wealth Boosts Mumbai’s Luxury Real Estate: Blue Jet Healthcare Promoter’s ₹202 Crore Purchase
The promoter of Blue Jet Healthcare and his family have purchased three luxury apartments in Worli, Mumbai, for over ₹202 crore, highlighting the growing trend of pharma wealth flowing into the city’s high-end real estate market.
Real Estate Pune
Jubilant Pharmova Reports 49% Surge in Profit After Tax to Rs 103 Crore
Jubilant Pharmova, a leading pharmaceutical company, has reported a significant 49% increase in profit after tax (PAT) to Rs 103 crore for the first quarter ended June 30, 2025. This marks a robust performance, driven by consistent revenue growth across all business units.
Real Estate Maharashtra
Maharashtra Allows Homeopaths to Practice Allopathy After 6-Month Course
The Maharashtra Medical Council has approved a six-month course that allows homeopaths to prescribe allopathic medicines, sparking concerns among medical professionals about patient safety and ethical standards.